80
Participants
Start Date
October 15, 2021
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments) during 12 months (baseline visit and follow-up visits at 3, 6 and 12 months).
Data collection: blood samples (analysed for EBV serology, auto-antibody-testing/biobanking, RNA expression analyses, procalcitonin)
Data collection: blood samples (analysed for EBV serology, auto-antibody-testing/biobanking, RNA expression analyses, procalcitonin) during 12 months (baseline visit and follow-up visits at 3, 6 and 12 months).
Data collection: Patient reported outcome (Fatigue questionnaires)
Data collection: Patient reported outcome (Fatigue questionnaires) at 6 and 12 months.
RECRUITING
University Hospital Basel, Division of Internal Medicine, Basel
University Hospital, Basel, Switzerland
OTHER